US Broker Ratings

NewAmsterdam Pharma (NAMS) Stock Analysis: Riding a 740% Revenue Growth Wave in the Biotech Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) has been catching the attention of investors with its remarkable 740.10% revenue growth, positioning itself as a compelling player in..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 16.90% Upside with Promising Phase 3 Trials

Belite Bio, Inc (NASDAQ: BLTE) stands out in the biotechnology sector, primarily due to its promising pipeline of therapeutics targeting retinal degenerative diseases. Based in San..

Merus N.V. (MRUS) Stock Analysis: Potential Growth in Biotech with 20.40% Revenue Growth

Merus N.V. (MRUS), a Netherlands-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to antibody therapeutics. With a market capitalization of..

Biohaven Ltd. (BHVN) Stock Analysis: A 209.94% Potential Upside Beckons Investors

Individual investors looking for high-growth opportunities in the biotech sector might want to place Biohaven Ltd. (BHVN) on their radar. With a potential upside of 209.94%,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Biotechnology Innovator with 80% Upside Potential

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing attention in the biotechnology sector, offering a promising investment opportunity. With its current stock price at $25.39 and an..

Vericel Corporation (VCEL) Stock Analysis: Biotech Innovator with 64.65% Potential Upside

Vericel Corporation (NASDAQ: VCEL), a burgeoning entity within the biotechnology sector, has captured the interest of investors with its promising growth trajectory and innovative healthcare solutions...

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Potential Upside of 87.82% Amid Robust Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD) presents an intriguing opportunity for investors looking to tap into the dynamic field of biotechnology, particularly in the niche market of..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 94% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the healthcare sector specializing in medical devices, is making waves with its innovative approach in the field..

Bausch Health Companies Inc. (BHC) Stock Analysis: Understanding the 15.93% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, has been capturing the attention of investors due to its strategic positioning in..

CONMED Corporation (CNMD) Stock Analysis: Unlocking a 40% Upside Potential in the Medical Devices Sector

CONMED Corporation (CNMD), a key player in the healthcare sector, primarily focuses on developing and manufacturing medical devices used in various surgical procedures. With a market..

LifeStance Health Group, Inc. (LFST) Investor Outlook: A 64.94% Potential Upside Awaits in the Mental Health Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) has been making waves in the healthcare sector, particularly within the outpatient mental health services industry. Based in Scottsdale, Arizona,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Biotechnology Innovator with a 19% Upside Potential

For investors seeking exposure to cutting-edge biotechnology, CRISPR Therapeutics AG (NASDAQ: CRSP) presents a compelling opportunity. As a leader in gene editing, the company is pioneering..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Potential 58% Upside with Strong Buy Ratings

CG Oncology, Inc. (CGON), a promising player in the biopharmaceutical landscape, is capturing investor attention with its avant-garde approach to bladder cancer treatment. This Irvine, California-based..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 28% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) stands as a compelling prospect in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market..

Veracyte, Inc. (VCYT) Investor Outlook: Unlocking a 19.54% Upside with Robust Diagnostic Innovations

Veracyte, Inc. (NASDAQ: VCYT), a key player in the healthcare sector, operates within the diagnostics and research industry. The company, headquartered in South San Francisco, California,..

DENTSPLY SIRONA Inc. (XRAY) Stock Report: Exploring a 33% Potential Upside Amidst Healthcare Innovations

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing investor attention with its robust..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Potential 172.17% Upside Awaits Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) is garnering significant attention from investors, and for good reason. The clinical-stage biopharmaceutical company, based in San Diego, California, is on..

Clover Health Investments (CLOV) Stock Analysis: Revenue Growth Shines Amidst Volatility

Clover Health Investments, Corp. (NASDAQ: CLOV), a player in the healthcare plans industry, has been drawing attention with its impressive revenue growth, despite some mixed signals..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Challenges with a 3% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the health information services industry, is attracting interest from investors with its compelling dividend yield of 3%. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds